Some blood biochemistry parameters during the cholinergic treatment of Alzheimer's disease

Neuroscience and Behavioral Physiology

Volumn 31, Issue 4, 2001, Pages 457-461

  Braginskaya, F I ^a,b   Zorina, O M ^a,b   Pal'mina, N P ^a,b   Gaintseva, V D ^a,b   Burlakova, E B ^a,b   Selezneva, N D ^a,b   Kolykhalov, I V ^a,b   Gavrilova, S I ^a,b  

^a EMANUEL INSTITUTE OF BIOCHEMICAL PHYSICS   (Russian Federation)

^b MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMIRIDINE; GLIATILINE; LIPID; NOOTROPIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; BLOOD CHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; FATTY ACID DESATURATION; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; TREATMENT OUTCOME;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; AMINOQUINOLINES; BUTYRYLCHOLINESTERASE; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 0034872617     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010405115973     Document Type: Article

References (23)

1. Synthetic bioantioxidants with acetylcholinesterase-inhibiting activity
2. Antioxidants and tumor chemotherapy
3. Alzheimer's disease
4. The question of the analysis of endogenous products of lipid peroxidation
5. The effects of chemotherapy on the total saturation and composition of plasma and erythrocyte phospholipids in patients with disseminated breast tumors
6. The unsaturatedness of blood lipids in patients with breast cancer
7. Determination of the degree of unsaturatedness in plasma lipids in children with diabetes
8. Oxidation damage in neurodegenerative diseases
9. New synthetic bioantioxidants - Acetylcholinesterases (AChE) inhibitors
10. Cholinergic drugs in Alzheimer's disease
11. Mini-mental state. A practical method of grading the cognitive state of patients for the clinician
12. Cholinesterase inhibitors for Alzheimer's therapy. Do they work?
13. Eptastigmine: A cholinergic approach to the treatment of Alzheimer's disease
14. Oxidative stress hypothesis in Alzheimer's disease
15. Clinical Global Impression (CGI)
16. Clinical diagnosis of Alzheimer's disease: Report of the NINCDC-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
17. Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL)
18. Present state and future development of the therapy of the Alzheimer diseases
19. Mechanism for autooxidation of polyunsaturated lipids
20. Amyloid-β hypothesis of Alzheimer's disease
21. The pathogenesis of Alzheimer's disease
22. Kinetics of cholinesterase inhibition by eptastigmine in man